Alan Korman
15PUBLICATIONS
146CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Mar 16, 2026
Improving Anti-CTLA-4 Therapies through Peptide Masking and Fragment Crystallizable Non-fucosylation: Preclinical Characterization of Three Novel Antibodies.Amy Jhatakia, Xin Sun, Alessandra Vaccaro
|Jan 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modeling.Karel F A Van Damme, Dorine Sichien, Katrien Van der Borght
|Nov 17, 2025
Endothelial cells as targets of immune checkpoint blockade.Alan J Korman, Matthew Taylor, F Stephen Hodi
|May 10, 2024
CD8+ T cell targeting of tumor antigens presented by HLA-E.Ravi F Iyer, Marieke C Verweij, Sujit S Nair
|Aug 18, 2022
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.Kent Thudium, Mark Selby, Julie A Zorn
|Jan 15, 2022
Author Correction: The foundations of immune checkpoint blockade and the ipilimumab approval decennial.Alan J Korman, Sarah C Garrett-Thomson, Nils Lonberg
Pageof 3
Frequent Collaborators
3 joint publications
Mark Selby
2 joint publications
Nils Lonberg
1 joint publications
Lauren Lever
1 joint publications
Jacob Slowinski
1 joint publications
Tyler J Van De Voort
1 joint publications
Stephen D Gillies
1 joint publications
Megan M Tu
1 joint publications
Abigail K Kimball
1 joint publications
Tina Cascone
1 joint publications
Krista Menard
